U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Thu Jul 06 22:44:19 UTC 2023
Edited
by admin
on Thu Jul 06 22:44:19 UTC 2023
Protein Type SINGLE-DOMAIN ANTIBODY
Protein Sub Type BIVALENT VHH
Sequence Origin CAMEL
Sequence Type COMPLETE
Record UNII
2R27AB6766
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
CAPLACIZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
IMMUNOGLOBULIN, ANTI-(HUMAN VON WILLEBRAND'S BLOOD-COAGULATION FACTOR VIII DOMAIN A1) (HUMAN-LAMA GLAMA DIMERIC HEAVY CHAIN FRAGMENT PMP12A2H1)
Systematic Name English
CAPLACIZUMAB [USAN]
Common Name English
IMMUNOGLOBULIN VH-LINKER-VH FRAGMENT, ANTI-(HOMO SAPIENS VWF (VON WILLEBRAND FACTOR) A1 DOMAIN), HUMANIZED MONOCLONAL ANTIBODY VH-LINKER-VH CHAIN (1-259) (HUMANIZED VH (HOMO SAPIENS IGHV3-23*04 (82.5%) -(IGHD)-IGHJ4*01 L123>Q (123) (8.8.21) (1-128)) -TRI
Systematic Name English
Caplacizumab [WHO-DD]
Common Name English
ALX-0081
Code English
caplacizumab [INN]
Common Name English
CAPLACIZUMAB [MI]
Common Name English
CAPLACIZUMAB [JAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1327
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
FDA ORPHAN DRUG 277909
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
WHO-ATC B01AX07
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
Code System Code Type Description
INN
9511
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
DRUG BANK
DB06081
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
SMS_ID
100000166854
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
CAS
915810-67-2
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
LACTMED
Caplacizumab
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
RXCUI
2110604
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
ALTERNATIVE
DAILYMED
2R27AB6766
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
USAN
AB-28
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
EVMPD
SUB181150
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
WIKIPEDIA
Caplacizumab
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
RXCUI
2110605
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
ChEMBL
CHEMBL2109624
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
MERCK INDEX
M12117
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
DRUG CENTRAL
5308
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
FDA UNII
2R27AB6766
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
NCI_THESAURUS
C128625
Created by admin on Thu Jul 06 22:44:19 UTC 2023 , Edited by admin on Thu Jul 06 22:44:19 UTC 2023
PRIMARY
From To
1_22 1_96
1_153 1_227
Related Record Type Details
INNOVATOR->PARENT
SUB_CONCEPT->SUBSTANCE
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL